Explore how DFMEA transforms product development by identifying potential risks, optimizing designs, and ensuring compliance ...

A durable time‑to‑market advantage in hardware development comes from deliberately designing for scale from day one.

It takes a long time, many different steps, and considerable cost, before a new drug can be approved for use as a medicine.

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

The annual show for the embedded electronics supply chain showcased many innovations in edge AI and connected, intelligent systems that can perceive and act in real time.

Software companies are always fielding feature requests from customers. The more companies can use AI to debug existing ...

University of Edinburgh spin-out BIOCAPTIVA secures £1.58m funding and launches its msX liquid biopsy technology in the US to improve cancer diagnostics and research.

The MTIA processors are the tech giant’s latest attempt to build its own AI hardware, even as it continues spending billions ...

Roche Holding AG expands Nvidia AI GPUs for drug R&D, tops peers with 3,500+ Blackwell chips, see value vs Eli Lilly and ...

We reached an important milestone in Q4 ahead of our prior expectations. During the quarter, a second customer adopted our AI ...

Honda's decision to kill its three EVs for the U.S. market will reverberate far beyond North America.